UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 83 filers reported holding UROGEN PHARMA LTD in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $213,000 | -8.6% | 24,500 | 0.0% | 0.00% | – |
Q4 2021 | $233,000 | -43.4% | 24,500 | 0.0% | 0.00% | – |
Q3 2021 | $412,000 | +10.2% | 24,500 | 0.0% | 0.00% | – |
Q2 2021 | $374,000 | -12.4% | 24,500 | +11.9% | 0.00% | – |
Q1 2021 | $427,000 | +8.1% | 21,900 | 0.0% | 0.00% | – |
Q4 2020 | $395,000 | -6.4% | 21,900 | 0.0% | 0.00% | – |
Q3 2020 | $422,000 | -26.2% | 21,900 | 0.0% | 0.00% | – |
Q2 2020 | $572,000 | +46.3% | 21,900 | 0.0% | 0.00% | – |
Q1 2020 | $391,000 | -46.5% | 21,900 | 0.0% | 0.00% | – |
Q4 2019 | $731,000 | +40.0% | 21,900 | 0.0% | 0.00% | – |
Q3 2019 | $522,000 | -33.7% | 21,900 | 0.0% | 0.00% | – |
Q2 2019 | $787,000 | – | 21,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |